- Home
- OCUL vs RXST Comparison
OCUL vs RXST Comparison
Compare OCUL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUL
- RXST
- Stock Information
- Founded
- OCUL 2006
- RXST 1997
- Country
- OCUL United States
- RXST United States
- Employees
- OCUL N/A
- RXST N/A
- Industry
- OCUL Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OCUL Health Care
- RXST Health Care
- Exchange
- OCUL Nasdaq
- RXST Nasdaq
- Market Cap
- OCUL 957.3M
- RXST 1.0B
- IPO Year
- OCUL 2014
- RXST 2021
- Fundamental
- Price
- OCUL $7.45
- RXST $13.23
- Analyst Decision
- OCUL Strong Buy
- RXST Buy
- Analyst Count
- OCUL 10
- RXST 10
- Target Price
- OCUL $16.11
- RXST $38.50
- AVG Volume (30 Days)
- OCUL 1.6M
- RXST 1.1M
- Earning Date
- OCUL 05-05-2025
- RXST 05-07-2025
- Dividend Yield
- OCUL N/A
- RXST N/A
- EPS Growth
- OCUL N/A
- RXST N/A
- EPS
- OCUL N/A
- RXST N/A
- Revenue
- OCUL $59,647,000.00
- RXST $148,310,000.00
- Revenue This Year
- OCUL $13.32
- RXST $24.14
- Revenue Next Year
- OCUL $13.13
- RXST $21.47
- P/E Ratio
- OCUL N/A
- RXST N/A
- Revenue Growth
- OCUL N/A
- RXST 46.70
- 52 Week Low
- OCUL $4.06
- RXST $13.50
- 52 Week High
- OCUL $11.78
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- OCUL 48.17
- RXST 32.97
- Support Level
- OCUL $8.07
- RXST $13.72
- Resistance Level
- OCUL $8.90
- RXST $16.03
- Average True Range (ATR)
- OCUL 0.48
- RXST 0.89
- MACD
- OCUL -0.08
- RXST 0.35
- Stochastic Oscillator
- OCUL 29.68
- RXST 0.53
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.